nodes	percent_of_prediction	percent_of_DWPC	metapath
Nevirapine—CYP2D6—Alzheimer's disease	0.279	1	CbGaD
Nevirapine—CYP2A6—Memantine—Alzheimer's disease	0.149	0.266	CbGbCtD
Nevirapine—CYP2B6—Memantine—Alzheimer's disease	0.097	0.173	CbGbCtD
Nevirapine—CYP2D6—Rivastigmine—Alzheimer's disease	0.0676	0.121	CbGbCtD
Nevirapine—CYP2C9—Donepezil—Alzheimer's disease	0.0591	0.105	CbGbCtD
Nevirapine—CYP2D6—Donepezil—Alzheimer's disease	0.054	0.0963	CbGbCtD
Nevirapine—CYP3A4—Rivastigmine—Alzheimer's disease	0.043	0.0766	CbGbCtD
Nevirapine—CYP2D6—Galantamine—Alzheimer's disease	0.0348	0.0621	CbGbCtD
Nevirapine—CYP3A4—Donepezil—Alzheimer's disease	0.0344	0.0613	CbGbCtD
Nevirapine—CYP3A4—Galantamine—Alzheimer's disease	0.0221	0.0395	CbGbCtD
Nevirapine—Surgery—Memantine—Alzheimer's disease	0.00528	0.0401	CcSEcCtD
Nevirapine—Surgical intervention—Memantine—Alzheimer's disease	0.00528	0.0401	CcSEcCtD
Nevirapine—Bullous eruption—Memantine—Alzheimer's disease	0.0028	0.0213	CcSEcCtD
Nevirapine—Hepatitis cholestatic—Memantine—Alzheimer's disease	0.00275	0.0209	CcSEcCtD
Nevirapine—Bullous eruption—Rivastigmine—Alzheimer's disease	0.00274	0.0208	CcSEcCtD
Nevirapine—Ulcerative stomatitis—Memantine—Alzheimer's disease	0.0024	0.0182	CcSEcCtD
Nevirapine—Ulcerative stomatitis—Rivastigmine—Alzheimer's disease	0.00235	0.0178	CcSEcCtD
Nevirapine—Transaminases increased—Donepezil—Alzheimer's disease	0.002	0.0152	CcSEcCtD
Nevirapine—Hepatic enzyme increased—Galantamine—Alzheimer's disease	0.00166	0.0126	CcSEcCtD
Nevirapine—Blister—Rivastigmine—Alzheimer's disease	0.0015	0.0114	CcSEcCtD
Nevirapine—Rash erythematous—Memantine—Alzheimer's disease	0.00145	0.011	CcSEcCtD
Nevirapine—Rash erythematous—Rivastigmine—Alzheimer's disease	0.00141	0.0107	CcSEcCtD
Nevirapine—Necrosis—Memantine—Alzheimer's disease	0.00141	0.0107	CcSEcCtD
Nevirapine—Gamma-glutamyltransferase increased—Memantine—Alzheimer's disease	0.00135	0.0102	CcSEcCtD
Nevirapine—Hypercholesterolaemia—Donepezil—Alzheimer's disease	0.00129	0.00979	CcSEcCtD
Nevirapine—Bone disorder—Memantine—Alzheimer's disease	0.00123	0.00931	CcSEcCtD
Nevirapine—Bone disorder—Rivastigmine—Alzheimer's disease	0.0012	0.00911	CcSEcCtD
Nevirapine—Hepatic enzyme increased—Memantine—Alzheimer's disease	0.00117	0.00889	CcSEcCtD
Nevirapine—Hypercholesterolaemia—Memantine—Alzheimer's disease	0.00117	0.00889	CcSEcCtD
Nevirapine—Hypercholesterolaemia—Rivastigmine—Alzheimer's disease	0.00115	0.0087	CcSEcCtD
Nevirapine—Inflammation—Rivastigmine—Alzheimer's disease	0.00112	0.00848	CcSEcCtD
Nevirapine—Skin exfoliation—Memantine—Alzheimer's disease	0.00106	0.00803	CcSEcCtD
Nevirapine—Skin exfoliation—Rivastigmine—Alzheimer's disease	0.00103	0.00785	CcSEcCtD
Nevirapine—Mouth ulceration—Memantine—Alzheimer's disease	0.001	0.0076	CcSEcCtD
Nevirapine—Rash maculo-papular—Rivastigmine—Alzheimer's disease	0.000984	0.00748	CcSEcCtD
Nevirapine—Mouth ulceration—Rivastigmine—Alzheimer's disease	0.000979	0.00744	CcSEcCtD
Nevirapine—Dermatitis bullous—Donepezil—Alzheimer's disease	0.000926	0.00703	CcSEcCtD
Nevirapine—Lymphadenopathy—Rivastigmine—Alzheimer's disease	0.000921	0.007	CcSEcCtD
Nevirapine—Hepatic failure—Memantine—Alzheimer's disease	0.000894	0.00679	CcSEcCtD
Nevirapine—Hyperglycaemia—Galantamine—Alzheimer's disease	0.00089	0.00676	CcSEcCtD
Nevirapine—Renal failure—Galantamine—Alzheimer's disease	0.000865	0.00657	CcSEcCtD
Nevirapine—Neuropathy peripheral—Galantamine—Alzheimer's disease	0.000863	0.00655	CcSEcCtD
Nevirapine—Face oedema—Donepezil—Alzheimer's disease	0.000854	0.00649	CcSEcCtD
Nevirapine—Dermatitis bullous—Memantine—Alzheimer's disease	0.000841	0.00639	CcSEcCtD
Nevirapine—Hepatobiliary disease—Galantamine—Alzheimer's disease	0.000832	0.00632	CcSEcCtD
Nevirapine—Dermatitis bullous—Rivastigmine—Alzheimer's disease	0.000823	0.00625	CcSEcCtD
Nevirapine—Liver function test abnormal—Donepezil—Alzheimer's disease	0.000817	0.00621	CcSEcCtD
Nevirapine—Aspartate aminotransferase increased—Donepezil—Alzheimer's disease	0.000797	0.00605	CcSEcCtD
Nevirapine—Hepatitis—Galantamine—Alzheimer's disease	0.00079	0.006	CcSEcCtD
Nevirapine—Alanine aminotransferase increased—Donepezil—Alzheimer's disease	0.000781	0.00593	CcSEcCtD
Nevirapine—Connective tissue disorder—Galantamine—Alzheimer's disease	0.000776	0.0059	CcSEcCtD
Nevirapine—Face oedema—Rivastigmine—Alzheimer's disease	0.000759	0.00576	CcSEcCtD
Nevirapine—Eosinophilia—Donepezil—Alzheimer's disease	0.000757	0.00575	CcSEcCtD
Nevirapine—Pancreatitis—Donepezil—Alzheimer's disease	0.00075	0.0057	CcSEcCtD
Nevirapine—Liver function test abnormal—Memantine—Alzheimer's disease	0.000742	0.00563	CcSEcCtD
Nevirapine—Liver function test abnormal—Rivastigmine—Alzheimer's disease	0.000726	0.00551	CcSEcCtD
Nevirapine—Aspartate aminotransferase increased—Memantine—Alzheimer's disease	0.000724	0.0055	CcSEcCtD
Nevirapine—Immune system disorder—Galantamine—Alzheimer's disease	0.000714	0.00542	CcSEcCtD
Nevirapine—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.000709	0.00538	CcSEcCtD
Nevirapine—Hyperglycaemia—Donepezil—Alzheimer's disease	0.00069	0.00524	CcSEcCtD
Nevirapine—Pancreatitis—Memantine—Alzheimer's disease	0.000681	0.00517	CcSEcCtD
Nevirapine—Renal failure—Donepezil—Alzheimer's disease	0.00067	0.00509	CcSEcCtD
Nevirapine—Pancreatitis—Rivastigmine—Alzheimer's disease	0.000666	0.00506	CcSEcCtD
Nevirapine—Jaundice—Donepezil—Alzheimer's disease	0.000665	0.00505	CcSEcCtD
Nevirapine—Conjunctivitis—Donepezil—Alzheimer's disease	0.000663	0.00504	CcSEcCtD
Nevirapine—Neutropenia—Memantine—Alzheimer's disease	0.000649	0.00493	CcSEcCtD
Nevirapine—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000638	0.00485	CcSEcCtD
Nevirapine—Anaemia—Galantamine—Alzheimer's disease	0.000636	0.00483	CcSEcCtD
Nevirapine—Hyperglycaemia—Memantine—Alzheimer's disease	0.000627	0.00476	CcSEcCtD
Nevirapine—Malaise—Galantamine—Alzheimer's disease	0.00062	0.00471	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.000614	0.00466	CcSEcCtD
Nevirapine—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000613	0.00466	CcSEcCtD
Nevirapine—Hepatitis—Donepezil—Alzheimer's disease	0.000612	0.00465	CcSEcCtD
Nevirapine—Renal failure—Memantine—Alzheimer's disease	0.000609	0.00462	CcSEcCtD
Nevirapine—Neuropathy peripheral—Memantine—Alzheimer's disease	0.000607	0.00461	CcSEcCtD
Nevirapine—Conjunctivitis—Memantine—Alzheimer's disease	0.000602	0.00457	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.000601	0.00456	CcSEcCtD
Nevirapine—Renal failure—Rivastigmine—Alzheimer's disease	0.000596	0.00452	CcSEcCtD
Nevirapine—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000594	0.00451	CcSEcCtD
Nevirapine—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000589	0.00447	CcSEcCtD
Nevirapine—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000586	0.00445	CcSEcCtD
Nevirapine—Arthralgia—Galantamine—Alzheimer's disease	0.000586	0.00445	CcSEcCtD
Nevirapine—Myalgia—Galantamine—Alzheimer's disease	0.000586	0.00445	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000582	0.00442	CcSEcCtD
Nevirapine—Discomfort—Galantamine—Alzheimer's disease	0.000579	0.00439	CcSEcCtD
Nevirapine—Agranulocytosis—Memantine—Alzheimer's disease	0.000578	0.00439	CcSEcCtD
Nevirapine—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000573	0.00435	CcSEcCtD
Nevirapine—Hepatitis—Memantine—Alzheimer's disease	0.000556	0.00422	CcSEcCtD
Nevirapine—Nervous system disorder—Galantamine—Alzheimer's disease	0.00055	0.00418	CcSEcCtD
Nevirapine—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00055	0.00417	CcSEcCtD
Nevirapine—Connective tissue disorder—Memantine—Alzheimer's disease	0.000546	0.00415	CcSEcCtD
Nevirapine—Skin disorder—Galantamine—Alzheimer's disease	0.000545	0.00414	CcSEcCtD
Nevirapine—Hepatitis—Rivastigmine—Alzheimer's disease	0.000544	0.00413	CcSEcCtD
Nevirapine—Anorexia—Galantamine—Alzheimer's disease	0.000535	0.00406	CcSEcCtD
Nevirapine—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000534	0.00406	CcSEcCtD
Nevirapine—Erythema—Donepezil—Alzheimer's disease	0.000533	0.00405	CcSEcCtD
Nevirapine—Erythema multiforme—Memantine—Alzheimer's disease	0.000526	0.00399	CcSEcCtD
Nevirapine—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000514	0.00391	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000511	0.00388	CcSEcCtD
Nevirapine—Paraesthesia—Galantamine—Alzheimer's disease	0.000504	0.00383	CcSEcCtD
Nevirapine—Immune system disorder—Memantine—Alzheimer's disease	0.000502	0.00381	CcSEcCtD
Nevirapine—Somnolence—Galantamine—Alzheimer's disease	0.000499	0.00379	CcSEcCtD
Nevirapine—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000495	0.00376	CcSEcCtD
Nevirapine—Anaemia—Donepezil—Alzheimer's disease	0.000493	0.00374	CcSEcCtD
Nevirapine—Decreased appetite—Galantamine—Alzheimer's disease	0.000488	0.00371	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000485	0.00368	CcSEcCtD
Nevirapine—Fatigue—Galantamine—Alzheimer's disease	0.000484	0.00368	CcSEcCtD
Nevirapine—Malaise—Donepezil—Alzheimer's disease	0.000481	0.00365	CcSEcCtD
Nevirapine—Erythema—Rivastigmine—Alzheimer's disease	0.000473	0.0036	CcSEcCtD
Nevirapine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000463	0.00351	CcSEcCtD
Nevirapine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000459	0.00349	CcSEcCtD
Nevirapine—Myalgia—Donepezil—Alzheimer's disease	0.000454	0.00345	CcSEcCtD
Nevirapine—Arthralgia—Donepezil—Alzheimer's disease	0.000454	0.00345	CcSEcCtD
Nevirapine—Ill-defined disorder—Memantine—Alzheimer's disease	0.000449	0.00341	CcSEcCtD
Nevirapine—Discomfort—Donepezil—Alzheimer's disease	0.000448	0.00341	CcSEcCtD
Nevirapine—Anaemia—Memantine—Alzheimer's disease	0.000447	0.0034	CcSEcCtD
Nevirapine—Abdominal pain—Galantamine—Alzheimer's disease	0.000444	0.00337	CcSEcCtD
Nevirapine—Body temperature increased—Galantamine—Alzheimer's disease	0.000444	0.00337	CcSEcCtD
Nevirapine—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000439	0.00334	CcSEcCtD
Nevirapine—Anaemia—Rivastigmine—Alzheimer's disease	0.000438	0.00332	CcSEcCtD
Nevirapine—Malaise—Memantine—Alzheimer's disease	0.000436	0.00331	CcSEcCtD
Nevirapine—Oedema—Donepezil—Alzheimer's disease	0.000435	0.0033	CcSEcCtD
Nevirapine—Malaise—Rivastigmine—Alzheimer's disease	0.000427	0.00324	CcSEcCtD
Nevirapine—Nervous system disorder—Donepezil—Alzheimer's disease	0.000427	0.00324	CcSEcCtD
Nevirapine—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000426	0.00323	CcSEcCtD
Nevirapine—Anorexia—Donepezil—Alzheimer's disease	0.000415	0.00315	CcSEcCtD
Nevirapine—Hypersensitivity—Galantamine—Alzheimer's disease	0.000414	0.00314	CcSEcCtD
Nevirapine—Myalgia—Memantine—Alzheimer's disease	0.000412	0.00313	CcSEcCtD
Nevirapine—Arthralgia—Memantine—Alzheimer's disease	0.000412	0.00313	CcSEcCtD
Nevirapine—Discomfort—Memantine—Alzheimer's disease	0.000407	0.00309	CcSEcCtD
Nevirapine—Myalgia—Rivastigmine—Alzheimer's disease	0.000403	0.00306	CcSEcCtD
Nevirapine—Arthralgia—Rivastigmine—Alzheimer's disease	0.000403	0.00306	CcSEcCtD
Nevirapine—Asthenia—Galantamine—Alzheimer's disease	0.000403	0.00306	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.0004	0.00304	CcSEcCtD
Nevirapine—Discomfort—Rivastigmine—Alzheimer's disease	0.000398	0.00302	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000396	0.00301	CcSEcCtD
Nevirapine—Oedema—Memantine—Alzheimer's disease	0.000395	0.003	CcSEcCtD
Nevirapine—Paraesthesia—Donepezil—Alzheimer's disease	0.000391	0.00297	CcSEcCtD
Nevirapine—Nervous system disorder—Memantine—Alzheimer's disease	0.000387	0.00294	CcSEcCtD
Nevirapine—Somnolence—Donepezil—Alzheimer's disease	0.000387	0.00294	CcSEcCtD
Nevirapine—Thrombocytopenia—Memantine—Alzheimer's disease	0.000387	0.00294	CcSEcCtD
Nevirapine—Oedema—Rivastigmine—Alzheimer's disease	0.000386	0.00293	CcSEcCtD
Nevirapine—Diarrhoea—Galantamine—Alzheimer's disease	0.000384	0.00292	CcSEcCtD
Nevirapine—Skin disorder—Memantine—Alzheimer's disease	0.000384	0.00291	CcSEcCtD
Nevirapine—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000379	0.00288	CcSEcCtD
Nevirapine—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000378	0.00287	CcSEcCtD
Nevirapine—Decreased appetite—Donepezil—Alzheimer's disease	0.000378	0.00287	CcSEcCtD
Nevirapine—Anorexia—Memantine—Alzheimer's disease	0.000377	0.00286	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000376	0.00285	CcSEcCtD
Nevirapine—Skin disorder—Rivastigmine—Alzheimer's disease	0.000375	0.00285	CcSEcCtD
Nevirapine—Fatigue—Donepezil—Alzheimer's disease	0.000375	0.00285	CcSEcCtD
Nevirapine—Pain—Donepezil—Alzheimer's disease	0.000372	0.00283	CcSEcCtD
Nevirapine—Anorexia—Rivastigmine—Alzheimer's disease	0.000368	0.0028	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.00036	0.00273	CcSEcCtD
Nevirapine—Feeling abnormal—Donepezil—Alzheimer's disease	0.000358	0.00272	CcSEcCtD
Nevirapine—Vomiting—Galantamine—Alzheimer's disease	0.000357	0.00271	CcSEcCtD
Nevirapine—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000356	0.0027	CcSEcCtD
Nevirapine—Paraesthesia—Memantine—Alzheimer's disease	0.000355	0.00269	CcSEcCtD
Nevirapine—Rash—Galantamine—Alzheimer's disease	0.000354	0.00269	CcSEcCtD
Nevirapine—Dermatitis—Galantamine—Alzheimer's disease	0.000354	0.00269	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000352	0.00267	CcSEcCtD
Nevirapine—Headache—Galantamine—Alzheimer's disease	0.000352	0.00267	CcSEcCtD
Nevirapine—Somnolence—Memantine—Alzheimer's disease	0.000351	0.00267	CcSEcCtD
Nevirapine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000347	0.00264	CcSEcCtD
Nevirapine—Urticaria—Donepezil—Alzheimer's disease	0.000346	0.00262	CcSEcCtD
Nevirapine—Abdominal pain—Donepezil—Alzheimer's disease	0.000344	0.00261	CcSEcCtD
Nevirapine—Body temperature increased—Donepezil—Alzheimer's disease	0.000344	0.00261	CcSEcCtD
Nevirapine—Somnolence—Rivastigmine—Alzheimer's disease	0.000344	0.00261	CcSEcCtD
Nevirapine—Decreased appetite—Memantine—Alzheimer's disease	0.000343	0.00261	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000341	0.00259	CcSEcCtD
Nevirapine—Fatigue—Memantine—Alzheimer's disease	0.000341	0.00259	CcSEcCtD
Nevirapine—Pain—Memantine—Alzheimer's disease	0.000338	0.00257	CcSEcCtD
Nevirapine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000336	0.00255	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000334	0.00253	CcSEcCtD
Nevirapine—Nausea—Galantamine—Alzheimer's disease	0.000333	0.00253	CcSEcCtD
Nevirapine—Fatigue—Rivastigmine—Alzheimer's disease	0.000333	0.00253	CcSEcCtD
Nevirapine—Pain—Rivastigmine—Alzheimer's disease	0.00033	0.00251	CcSEcCtD
Nevirapine—Feeling abnormal—Memantine—Alzheimer's disease	0.000325	0.00247	CcSEcCtD
Nevirapine—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000323	0.00245	CcSEcCtD
Nevirapine—Hypersensitivity—Donepezil—Alzheimer's disease	0.000321	0.00243	CcSEcCtD
Nevirapine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000318	0.00242	CcSEcCtD
Nevirapine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000316	0.0024	CcSEcCtD
Nevirapine—Urticaria—Memantine—Alzheimer's disease	0.000314	0.00238	CcSEcCtD
Nevirapine—Body temperature increased—Memantine—Alzheimer's disease	0.000312	0.00237	CcSEcCtD
Nevirapine—Abdominal pain—Memantine—Alzheimer's disease	0.000312	0.00237	CcSEcCtD
Nevirapine—Asthenia—Donepezil—Alzheimer's disease	0.000312	0.00237	CcSEcCtD
Nevirapine—Pruritus—Donepezil—Alzheimer's disease	0.000308	0.00234	CcSEcCtD
Nevirapine—Urticaria—Rivastigmine—Alzheimer's disease	0.000307	0.00233	CcSEcCtD
Nevirapine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000305	0.00232	CcSEcCtD
Nevirapine—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000305	0.00232	CcSEcCtD
Nevirapine—Diarrhoea—Donepezil—Alzheimer's disease	0.000298	0.00226	CcSEcCtD
Nevirapine—Hypersensitivity—Memantine—Alzheimer's disease	0.000291	0.00221	CcSEcCtD
Nevirapine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000285	0.00216	CcSEcCtD
Nevirapine—Asthenia—Memantine—Alzheimer's disease	0.000283	0.00215	CcSEcCtD
Nevirapine—Pruritus—Memantine—Alzheimer's disease	0.000279	0.00212	CcSEcCtD
Nevirapine—Asthenia—Rivastigmine—Alzheimer's disease	0.000277	0.00211	CcSEcCtD
Nevirapine—Vomiting—Donepezil—Alzheimer's disease	0.000277	0.0021	CcSEcCtD
Nevirapine—Rash—Donepezil—Alzheimer's disease	0.000274	0.00208	CcSEcCtD
Nevirapine—Dermatitis—Donepezil—Alzheimer's disease	0.000274	0.00208	CcSEcCtD
Nevirapine—Pruritus—Rivastigmine—Alzheimer's disease	0.000273	0.00208	CcSEcCtD
Nevirapine—Headache—Donepezil—Alzheimer's disease	0.000273	0.00207	CcSEcCtD
Nevirapine—Diarrhoea—Memantine—Alzheimer's disease	0.00027	0.00205	CcSEcCtD
Nevirapine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000264	0.00201	CcSEcCtD
Nevirapine—Nausea—Donepezil—Alzheimer's disease	0.000258	0.00196	CcSEcCtD
Nevirapine—Vomiting—Memantine—Alzheimer's disease	0.000251	0.00191	CcSEcCtD
Nevirapine—Rash—Memantine—Alzheimer's disease	0.000249	0.00189	CcSEcCtD
Nevirapine—Dermatitis—Memantine—Alzheimer's disease	0.000249	0.00189	CcSEcCtD
Nevirapine—Headache—Memantine—Alzheimer's disease	0.000247	0.00188	CcSEcCtD
Nevirapine—Vomiting—Rivastigmine—Alzheimer's disease	0.000246	0.00187	CcSEcCtD
Nevirapine—Rash—Rivastigmine—Alzheimer's disease	0.000244	0.00185	CcSEcCtD
Nevirapine—Dermatitis—Rivastigmine—Alzheimer's disease	0.000243	0.00185	CcSEcCtD
Nevirapine—Headache—Rivastigmine—Alzheimer's disease	0.000242	0.00184	CcSEcCtD
Nevirapine—Nausea—Memantine—Alzheimer's disease	0.000235	0.00178	CcSEcCtD
Nevirapine—Nausea—Rivastigmine—Alzheimer's disease	0.00023	0.00174	CcSEcCtD
Nevirapine—CYP2B6—Metabolism—GAPDHS—Alzheimer's disease	2.67e-05	0.00094	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—ND1—Alzheimer's disease	2.67e-05	0.000939	CbGpPWpGaD
Nevirapine—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	2.63e-05	0.000924	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GAPDHS—Alzheimer's disease	2.61e-05	0.000919	CbGpPWpGaD
Nevirapine—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	2.59e-05	0.000912	CbGpPWpGaD
Nevirapine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Alzheimer's disease	2.58e-05	0.000908	CbGpPWpGaD
Nevirapine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Alzheimer's disease	2.58e-05	0.000908	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ATP5A1—Alzheimer's disease	2.53e-05	0.000891	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ATP5A1—Alzheimer's disease	2.48e-05	0.000871	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PLD3—Alzheimer's disease	2.42e-05	0.00085	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PLD3—Alzheimer's disease	2.36e-05	0.000831	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—DHCR24—Alzheimer's disease	2.32e-05	0.000817	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—HSD17B10—Alzheimer's disease	2.32e-05	0.000815	CbGpPWpGaD
Nevirapine—CYP2A6—NRF2 pathway—TGFB1—Alzheimer's disease	2.31e-05	0.000812	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—DHCR24—Alzheimer's disease	2.3e-05	0.00081	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—HSD17B10—Alzheimer's disease	2.26e-05	0.000797	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CYP46A1—Alzheimer's disease	2.23e-05	0.000785	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CYP46A1—Alzheimer's disease	2.18e-05	0.000767	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ND1—Alzheimer's disease	2.15e-05	0.000758	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	2.15e-05	0.000755	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ND1—Alzheimer's disease	2.11e-05	0.000741	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CA4—Alzheimer's disease	1.98e-05	0.000695	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—DHCR24—Alzheimer's disease	1.97e-05	0.000692	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CA4—Alzheimer's disease	1.96e-05	0.000689	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	1.91e-05	0.000673	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GAPDHS—Alzheimer's disease	1.86e-05	0.000653	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GAPDHS—Alzheimer's disease	1.84e-05	0.000648	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	1.84e-05	0.000646	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ATP5A1—Alzheimer's disease	1.76e-05	0.000619	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ATP5A1—Alzheimer's disease	1.75e-05	0.000614	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—CHAT—Alzheimer's disease	1.72e-05	0.000605	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—TPI1—Alzheimer's disease	1.72e-05	0.000605	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PLD3—Alzheimer's disease	1.68e-05	0.000591	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CA4—Alzheimer's disease	1.67e-05	0.000589	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PLD3—Alzheimer's disease	1.67e-05	0.000586	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	1.67e-05	0.000586	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—MAOB—Alzheimer's disease	1.65e-05	0.00058	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	1.65e-05	0.000579	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	1.64e-05	0.000575	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	1.61e-05	0.000566	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—HSD17B10—Alzheimer's disease	1.6e-05	0.000562	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—GAPDH—Alzheimer's disease	1.59e-05	0.000558	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GAPDHS—Alzheimer's disease	1.57e-05	0.000553	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	1.56e-05	0.000549	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	1.55e-05	0.000545	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CYP46A1—Alzheimer's disease	1.54e-05	0.000541	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—A2M—Alzheimer's disease	1.53e-05	0.000539	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	1.52e-05	0.000534	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ND1—Alzheimer's disease	1.5e-05	0.000527	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ATP5A1—Alzheimer's disease	1.49e-05	0.000525	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ND1—Alzheimer's disease	1.48e-05	0.000522	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.45e-05	0.00051	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PLD3—Alzheimer's disease	1.42e-05	0.000501	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	1.42e-05	0.000501	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	1.41e-05	0.000495	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CHAT—Alzheimer's disease	1.39e-05	0.000488	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—TPI1—Alzheimer's disease	1.39e-05	0.000488	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—HSD17B10—Alzheimer's disease	1.36e-05	0.00048	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—TPI1—Alzheimer's disease	1.36e-05	0.000477	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CHAT—Alzheimer's disease	1.36e-05	0.000477	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—ACHE—Alzheimer's disease	1.33e-05	0.000469	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	1.33e-05	0.000469	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—MAOB—Alzheimer's disease	1.33e-05	0.000468	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.33e-05	0.000467	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—INPP5D—Alzheimer's disease	1.32e-05	0.000464	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CYP46A1—Alzheimer's disease	1.31e-05	0.000462	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—MAOB—Alzheimer's disease	1.3e-05	0.000458	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CA4—Alzheimer's disease	1.29e-05	0.000454	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GAPDH—Alzheimer's disease	1.28e-05	0.000451	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ND1—Alzheimer's disease	1.27e-05	0.000446	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GAPDH—Alzheimer's disease	1.25e-05	0.00044	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—ENO1—Alzheimer's disease	1.25e-05	0.00044	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PTGS1—Alzheimer's disease	1.25e-05	0.00044	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.24e-05	0.000436	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—A2M—Alzheimer's disease	1.24e-05	0.000435	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—CYP2D6—Alzheimer's disease	1.23e-05	0.000431	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	1.21e-05	0.000427	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—A2M—Alzheimer's disease	1.21e-05	0.000425	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—BCHE—Alzheimer's disease	1.16e-05	0.000409	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.15e-05	0.000405	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.14e-05	0.000402	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.13e-05	0.000399	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.1e-05	0.000386	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PLCB1—Alzheimer's disease	1.1e-05	0.000386	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ACHE—Alzheimer's disease	1.08e-05	0.000379	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—INPP5D—Alzheimer's disease	1.06e-05	0.000374	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—ABCA1—Alzheimer's disease	1.06e-05	0.000374	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.05e-05	0.00037	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ACHE—Alzheimer's disease	1.05e-05	0.00037	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.04e-05	0.000366	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—INPP5D—Alzheimer's disease	1.04e-05	0.000366	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.01e-05	0.000357	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ENO1—Alzheimer's disease	1.01e-05	0.000355	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PTGS1—Alzheimer's disease	1.01e-05	0.000355	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CYP2D6—Alzheimer's disease	9.89e-06	0.000348	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ENO1—Alzheimer's disease	9.86e-06	0.000347	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PTGS1—Alzheimer's disease	9.86e-06	0.000347	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ND1—Alzheimer's disease	9.79e-06	0.000344	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	9.77e-06	0.000344	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CYP2D6—Alzheimer's disease	9.67e-06	0.00034	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CHAT—Alzheimer's disease	9.65e-06	0.000339	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—TPI1—Alzheimer's disease	9.65e-06	0.000339	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—TPI1—Alzheimer's disease	9.56e-06	0.000336	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CHAT—Alzheimer's disease	9.56e-06	0.000336	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—BCHE—Alzheimer's disease	9.38e-06	0.00033	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—MAOB—Alzheimer's disease	9.25e-06	0.000325	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—MAOB—Alzheimer's disease	9.17e-06	0.000323	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—BCHE—Alzheimer's disease	9.16e-06	0.000322	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PPARGC1A—Alzheimer's disease	9.16e-06	0.000322	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—HMOX1—Alzheimer's disease	9.12e-06	0.000321	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	8.9e-06	0.000313	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	8.9e-06	0.000313	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PLCB1—Alzheimer's disease	8.85e-06	0.000311	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	8.83e-06	0.00031	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	8.73e-06	0.000307	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PLCB1—Alzheimer's disease	8.65e-06	0.000304	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	8.65e-06	0.000304	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—A2M—Alzheimer's disease	8.6e-06	0.000302	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ABCA1—Alzheimer's disease	8.58e-06	0.000302	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—A2M—Alzheimer's disease	8.52e-06	0.0003	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ABCA1—Alzheimer's disease	8.38e-06	0.000295	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—LPL—Alzheimer's disease	8.34e-06	0.000293	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—TPI1—Alzheimer's disease	8.17e-06	0.000287	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CHAT—Alzheimer's disease	8.17e-06	0.000287	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—MAOB—Alzheimer's disease	7.84e-06	0.000276	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	7.6e-06	0.000267	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	7.54e-06	0.000265	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—MTHFR—Alzheimer's disease	7.51e-06	0.000264	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ACHE—Alzheimer's disease	7.48e-06	0.000263	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	7.46e-06	0.000262	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ACHE—Alzheimer's disease	7.42e-06	0.000261	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	7.39e-06	0.00026	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PPARGC1A—Alzheimer's disease	7.39e-06	0.00026	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	7.39e-06	0.00026	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—HMOX1—Alzheimer's disease	7.36e-06	0.000259	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	7.33e-06	0.000258	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—A2M—Alzheimer's disease	7.28e-06	0.000256	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PPARGC1A—Alzheimer's disease	7.22e-06	0.000254	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—HMOX1—Alzheimer's disease	7.19e-06	0.000253	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—CALM1—Alzheimer's disease	7.02e-06	0.000247	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ENO1—Alzheimer's disease	7.01e-06	0.000247	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	7.01e-06	0.000247	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—APOE—Alzheimer's disease	6.99e-06	0.000246	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ENO1—Alzheimer's disease	6.95e-06	0.000244	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	6.95e-06	0.000244	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—CAV1—Alzheimer's disease	6.93e-06	0.000244	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	6.81e-06	0.00024	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—LPL—Alzheimer's disease	6.73e-06	0.000237	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—LPL—Alzheimer's disease	6.58e-06	0.000231	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—BCHE—Alzheimer's disease	6.52e-06	0.000229	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	6.5e-06	0.000228	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—BCHE—Alzheimer's disease	6.46e-06	0.000227	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ACHE—Alzheimer's disease	6.34e-06	0.000223	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CHAT—Alzheimer's disease	6.31e-06	0.000222	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—TPI1—Alzheimer's disease	6.31e-06	0.000222	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	6.26e-06	0.00022	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	6.15e-06	0.000216	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	6.1e-06	0.000214	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PPARG—Alzheimer's disease	6.09e-06	0.000214	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—MTHFR—Alzheimer's disease	6.06e-06	0.000213	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—MAOB—Alzheimer's disease	6.05e-06	0.000213	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	5.98e-06	0.00021	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—INS—Alzheimer's disease	5.97e-06	0.00021	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	5.96e-06	0.00021	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	5.94e-06	0.000209	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ENO1—Alzheimer's disease	5.94e-06	0.000209	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—MTHFR—Alzheimer's disease	5.92e-06	0.000208	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	5.91e-06	0.000208	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	5.82e-06	0.000205	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	5.82e-06	0.000205	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CALM1—Alzheimer's disease	5.66e-06	0.000199	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—APOE—Alzheimer's disease	5.64e-06	0.000198	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—A2M—Alzheimer's disease	5.62e-06	0.000198	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CAV1—Alzheimer's disease	5.59e-06	0.000197	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CALM1—Alzheimer's disease	5.53e-06	0.000195	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—BCHE—Alzheimer's disease	5.52e-06	0.000194	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—APOE—Alzheimer's disease	5.51e-06	0.000194	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CAV1—Alzheimer's disease	5.46e-06	0.000192	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—NOS3—Alzheimer's disease	5.24e-06	0.000184	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	5.21e-06	0.000183	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	5.14e-06	0.000181	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	5.11e-06	0.00018	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	5.11e-06	0.00018	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	5.09e-06	0.000179	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	5.07e-06	0.000178	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	5.05e-06	0.000178	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PPARG—Alzheimer's disease	4.91e-06	0.000173	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	4.89e-06	0.000172	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	4.83e-06	0.00017	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—INS—Alzheimer's disease	4.82e-06	0.00017	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PPARG—Alzheimer's disease	4.8e-06	0.000169	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PTGS2—Alzheimer's disease	4.79e-06	0.000168	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—INS—Alzheimer's disease	4.71e-06	0.000166	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—LPL—Alzheimer's disease	4.68e-06	0.000165	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—LPL—Alzheimer's disease	4.64e-06	0.000163	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	4.58e-06	0.000161	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	4.58e-06	0.000161	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	4.49e-06	0.000158	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	4.35e-06	0.000153	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	4.33e-06	0.000152	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	4.26e-06	0.00015	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—NOS3—Alzheimer's disease	4.23e-06	0.000149	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	4.21e-06	0.000148	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	4.17e-06	0.000147	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—NOS3—Alzheimer's disease	4.13e-06	0.000145	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	4.02e-06	0.000141	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—LPL—Alzheimer's disease	3.96e-06	0.000139	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CALM1—Alzheimer's disease	3.93e-06	0.000138	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—APOE—Alzheimer's disease	3.92e-06	0.000138	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CALM1—Alzheimer's disease	3.9e-06	0.000137	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	3.9e-06	0.000137	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—APOE—Alzheimer's disease	3.89e-06	0.000137	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CAV1—Alzheimer's disease	3.88e-06	0.000137	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PTGS2—Alzheimer's disease	3.86e-06	0.000136	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CAV1—Alzheimer's disease	3.85e-06	0.000135	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	3.78e-06	0.000133	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	3.57e-06	0.000125	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PPARG—Alzheimer's disease	3.41e-06	0.00012	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PPARG—Alzheimer's disease	3.39e-06	0.000119	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	3.36e-06	0.000118	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—INS—Alzheimer's disease	3.35e-06	0.000118	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	3.34e-06	0.000118	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CALM1—Alzheimer's disease	3.33e-06	0.000117	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—APOE—Alzheimer's disease	3.32e-06	0.000117	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—INS—Alzheimer's disease	3.32e-06	0.000117	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CAV1—Alzheimer's disease	3.29e-06	0.000116	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—LPL—Alzheimer's disease	3.06e-06	0.000108	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—NOS3—Alzheimer's disease	2.94e-06	0.000103	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—NOS3—Alzheimer's disease	2.91e-06	0.000102	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PPARG—Alzheimer's disease	2.89e-06	0.000102	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—INS—Alzheimer's disease	2.84e-06	9.98e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	2.75e-06	9.68e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	2.69e-06	9.45e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	2.66e-06	9.37e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	2.57e-06	9.05e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—APOE—Alzheimer's disease	2.56e-06	9.02e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	2.54e-06	8.93e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—NOS3—Alzheimer's disease	2.49e-06	8.75e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—AKT1—Alzheimer's disease	2.41e-06	8.47e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	2.28e-06	8e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	2.23e-06	7.85e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—INS—Alzheimer's disease	2.19e-06	7.7e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—AKT1—Alzheimer's disease	1.94e-06	6.83e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.92e-06	6.75e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—AKT1—Alzheimer's disease	1.9e-06	6.68e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.76e-06	6.18e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.35e-06	4.75e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—AKT1—Alzheimer's disease	1.34e-06	4.71e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—AKT1—Alzheimer's disease	1.14e-06	4.02e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	8.83e-07	3.1e-05	CbGpPWpGaD
